Trial · NCT02618577
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Composite of Stroke, Systemic Embolism, or Cardiovascular Death | Edoxaban | 3.3 | number of new events per 100 pat.-years | ||
| Composite of Stroke, Systemic Embolism, or Cardiovascular Death | ASA or Placebo | 4.0 | number of new events per 100 pat.-years | ||
| Components of the Primary Outcome, Stroke | Edoxaban | 0.9 | number of new events per 100 pat.-years | ||
| Components of the Primary Outcome, Stroke | ASA or Placebo | 1.1 | number of new events per 100 pat.-years | ||
| Major Adverse Cardiac Events (MACEs: Cardiac Death, Myocardial Infarction, Acute Coronary Syndrome (ACS) | Edoxaban | 3.6 | number of new events per 100 pat.-years | ||
| Major Adverse Cardiac Events (MACEs: Cardiac Death, Myocardial Infarction, Acute Coronary Syndrome (ACS) | ASA or Placebo | 4.1 | number of new events per 100 pat.-years | ||
| All-cause Death | Edoxaban | 4.3 | number of new events per 100 pat.-years | ||
| All-cause Death | ASA or Placebo | 3.7 | number of new events per 100 pat.-years | ||
| Major Bleeding Events | Edoxaban | 2.1 | number of new events per 100 pat.-years | ||
| Major Bleeding Events | ASA or Placebo | 1.0 | number of new events per 100 pat.-years | ||
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | Edoxaban | EQ-5D-5L UK Index to FU12 | -0.01 | 95% Confidence Interval -0.03 to 0 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | ASA or Placebo | EQ-5D-5L UK Index to FU12 | -0.01 | 95% Confidence Interval -0.02 to 0.01 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | Edoxaban | EQ-5D-5L UK Index to FU24 | -0.04 | 95% Confidence Interval -0.05 to -0.02 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | ASA or Placebo | EQ-5D-5L UK Index to FU24 | -0.03 | 95% Confidence Interval -0.05 to -0.02 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | Edoxaban | EQ-5D-5L VAS to FU12 | -0.75 | 95% Confidence Interval -2.08 to 0.57 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | ASA or Placebo | EQ-5D-5L VAS to FU12 | -0.71 | 95% Confidence Interval -2.06 to 0.64 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | Edoxaban | EQ-5D-5L VAS to FU24 | -1.72 | 95% Confidence Interval -3.18 to -0.27 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | ASA or Placebo | EQ-5D-5L VAS to FU24 | -1.68 | 95% Confidence Interval -3.16 to 0.20 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | Edoxaban | Karnofsky score to FU12 | -1.14 | 95% Confidence Interval -1.98 to -0.31 | adjusted mean change from baseline |
| Quality of Life Changes at 12 and 24 Months Compared to Baseline | ASA or Placebo | Karnofsky score to FU12 | -1.41 | 95% Confidence Interval -2.26 to -0.57 | adjusted mean change from baseline |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02618577/results